Financhill
Buy
57

EW Quote, Financials, Valuation and Earnings

Last price:
$75.67
Seasonality move :
5.55%
Day range:
$74.92 - $75.95
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
10.96x
P/S ratio:
6.94x
P/B ratio:
4.69x
Volume:
3M
Avg. volume:
5.2M
1-year change:
-0.47%
Market cap:
$44.8B
Revenue:
$6B
EPS (TTM):
$6.93

Earnings Data

Next earnings date for EW
Feb 06
2025
Most recent earnings per share
$5.13
Beat by $4.54
(Oct 24/2024)
Consensus Estimate
$0.59
(Oct 24/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EW Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/06/2025 Q4 $1.4B -- -- $0.55 --
10/24/2024 Q3 $1.4B $1.4B $5.13 $0.59 $4.54
07/24/2024 Q2 $1.7B $1.4B $0.61 $0.69 -$0.08
04/25/2024 Q1 $1.6B $1.6B $0.58 $0.64 -$0.06
02/06/2024 Q4 $1.5B $2.3B $0.61 $0.64 -$0.03
10/25/2023 Q3 -- -- $0.63 $0.59 $0.04
06/30/2023 Q2 -- -- $0.50 $0.65 -$0.15
03/31/2023 Q1 -- -- $0.56 $0.61 -$0.05
12/31/2022 Q4 -- -- $0.65 $0.61 $0.04
09/30/2022 Q3 -- -- $0.55 $0.62 -$0.07
06/30/2022 Q2 -- -- $0.65 $0.64 $0.01
03/31/2022 Q1 -- -- $0.59 $0.57 $0.02
12/31/2021 Q4 -- -- $0.53 $0.55 -$0.02
09/30/2021 Q3 -- -- $0.54 $0.53 $0.01
06/30/2021 Q2 -- -- $0.78 -- --
03/31/2021 Q1 -- -- $0.54 -- --
12/31/2020 Q4 -- -- $0.49 -- --
09/30/2020 Q3 -- -- $0.52 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- $0.49 -- --
12/31/2019 Q4 -- -- $0.44 -- --
09/30/2019 Q3 -- -- $0.43 -- --
06/30/2019 Q2 -- -- $0.38 -- --
03/31/2019 Q1 -- -- $0.39 -- --
12/31/2018 Q4 -- -- $0.01 -- --
09/30/2018 Q3 -- -- $0.35 -- --
06/30/2018 Q2 -- -- $0.44 -- --
03/31/2018 Q1 -- -- $0.32 -- --
12/31/2017 Q4 -- -- $0.06 -- --
09/30/2017 Q3 -- -- $0.26 -- --
06/30/2017 Q2 -- -- $0.29 -- --
03/31/2017 Q1 -- -- $0.35 -- --
12/31/2016 Q4 -- -- $0.24 -- --
09/30/2016 Q3 -- -- $0.22 -- --
06/30/2016 Q2 -- -- $0.19 -- --
03/31/2016 Q1 -- -- $0.22 -- --
12/31/2015 Q4 -- -- $0.21 -- --
09/30/2015 Q3 -- -- $0.18 -- --
06/30/2015 Q2 -- -- $0.17 -- --
03/31/2015 Q1 -- -- $0.19 -- --
12/31/2014 Q4 -- -- $0.17 -- --

Edwards Lifesciences Earnings Questions

  • How Much did Edwards Lifesciences Generate in Revenue Last Quarter?

    Edwards Lifesciences reported $1.4B worth of top line sales in its most recent quarter.

  • Did Edwards Lifesciences Beat Earnings Last Quarter?

    Edwards Lifesciences announced earnings per share of $5.13 which represents a beat of analyst forecast a $0.59 per share.

  • Is Edwards Lifesciences Profitable?

    Edwards Lifesciences reported $1.1B that represents $1.82 per share over the last quarter.

  • What is the Analyst Consensus for Edwards Lifesciences EPS Next Year?

    Edwards Lifesciences's earnings are forecast to grow from $2.30 per share to $2.51 per share next year representing an increase of 9.97%.

  • When is Edwards Lifesciences's Earnings Date?

    Edwards Lifesciences's next earnings date is February 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock